183 related articles for article (PubMed ID: 15067094)
1. Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway.
Gockel HR; Lügering A; Heidemann J; Schmidt M; Domschke W; Kucharzik T; Lügering N
J Immunol; 2004 Apr; 172(8):5103-9. PubMed ID: 15067094
[TBL] [Abstract][Full Text] [Related]
2. Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis.
Schmidt M; Lügering N; Lügering A; Pauels HG; Schulze-Osthoff K; Domschke W; Kucharzik T
J Immunol; 2001 Jan; 166(2):1344-51. PubMed ID: 11145719
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
[TBL] [Abstract][Full Text] [Related]
4. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
Strauss G; Knape I; Melzner I; Debatin KM
J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
[TBL] [Abstract][Full Text] [Related]
5. The Fas-FasL death receptor and PI3K pathways independently regulate monocyte homeostasis.
Perlman H; Pagliari LJ; Nguyen N; Bradley K; Liu H; Pope RM
Eur J Immunol; 2001 Aug; 31(8):2421-30. PubMed ID: 11500826
[TBL] [Abstract][Full Text] [Related]
6. TNF-related apoptosis-inducing ligand-induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria.
Thomas WD; Zhang XD; Franco AV; Nguyen T; Hersey P
J Immunol; 2000 Nov; 165(10):5612-20. PubMed ID: 11067917
[TBL] [Abstract][Full Text] [Related]
7. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway.
Lügering A; Schmidt M; Lügering N; Pauels HG; Domschke W; Kucharzik T
Gastroenterology; 2001 Nov; 121(5):1145-57. PubMed ID: 11677207
[TBL] [Abstract][Full Text] [Related]
8. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP.
Rokhlin OW; Guseva NV; Tagiyev AF; Glover RA; Cohen MB
Prostate; 2002 Jun; 52(1):1-11. PubMed ID: 11992615
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway.
Chou AH; Tsai HF; Wu YY; Hu CY; Hwang LH; Hsu PI; Hsu PN
J Immunol; 2005 Feb; 174(4):2160-6. PubMed ID: 15699147
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes.
Osawa Y; Banno Y; Nagaki M; Brenner DA; Naiki T; Nozawa Y; Nakashima S; Moriwaki H
J Immunol; 2001 Jul; 167(1):173-80. PubMed ID: 11418646
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent.
Inman GJ; Allday MJ
J Immunol; 2000 Sep; 165(5):2500-10. PubMed ID: 10946276
[TBL] [Abstract][Full Text] [Related]
12. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
Kandasamy K; Srivastava RK
Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743
[TBL] [Abstract][Full Text] [Related]
13. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3-kinase/Akt positively regulates Fas (CD95)-mediated apoptosis in epidermal Cl41 cells.
Lu B; Wang L; Stehlik C; Medan D; Huang C; Hu S; Chen F; Shi X; Rojanasakul Y
J Immunol; 2006 Jun; 176(11):6785-93. PubMed ID: 16709838
[TBL] [Abstract][Full Text] [Related]
15. Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling.
Perchellet EM; Wang Y; Weber RL; Lou K; Hua DH; Perchellet JP
Anticancer Drugs; 2004 Nov; 15(10):929-46. PubMed ID: 15514562
[TBL] [Abstract][Full Text] [Related]
16. Caspase-3 is a component of Fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during Fas-mediated cell death.
Aouad SM; Cohen LY; Sharif-Askari E; Haddad EK; Alam A; Sekaly RP
J Immunol; 2004 Feb; 172(4):2316-23. PubMed ID: 14764700
[TBL] [Abstract][Full Text] [Related]
17. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway.
Soane L; Cho HJ; Niculescu F; Rus H; Shin ML
J Immunol; 2001 Aug; 167(4):2305-11. PubMed ID: 11490019
[TBL] [Abstract][Full Text] [Related]
18. Rosmarinic acid induces p56lck-dependent apoptosis in Jurkat and peripheral T cells via mitochondrial pathway independent from Fas/Fas ligand interaction.
Hur YG; Yun Y; Won J
J Immunol; 2004 Jan; 172(1):79-87. PubMed ID: 14688312
[TBL] [Abstract][Full Text] [Related]
19. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation.
MacFarlane M; Cohen GM; Dickens M
Biochem J; 2000 May; 348 Pt 1(Pt 1):93-101. PubMed ID: 10794718
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release.
Gibson EM; Henson ES; Haney N; Villanueva J; Gibson SB
Cancer Res; 2002 Jan; 62(2):488-96. PubMed ID: 11809700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]